Table 2 Patients treatment modalities by BMI

From: Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index

 

BMI

 
 

Arm A BMI<25 kg m −2

Arm B BMI⩾25 kg m −2

 

Characteristic

n

%

n

%

P -value

Total

102

100

399

100

 

Chemotherapy

 No

6

5.9

24

6.0

0.85

 Adjuvant

90

88.2

337

84.5

 

 Neoadjuvant

6

5.9

38

9.5

 

Chemotherapetic agents

 Antracycline

38

39.6

157

41.9

0.64

 Taxanes

30

31.2

134

35.7

 

 Trastuzumab

16

16.7

54

14.4

 

 Others

12

12.5

30

8.0

 

Radiotherapy

 No

34

33.3

119

29.8

0.44

 Yes

68

66.7

280

70.2

 

Hormonal treatment

 Anastrozole

39

38.2

174

43.6

0.37

 Letrozole

63

61.8

225

56.4

 
  1. Abbreviation: BMI=body mass index.
Back to article page